Antihypertensive treatment in people with dementia.

[1]  J. Gladman,et al.  The evidence for treating hypertension in older people with dementia: a systematic review , 2014, Journal of Human Hypertension.

[2]  R. Ownby,et al.  Subtypes of sleep problems in patients with Alzheimer disease. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[3]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[4]  M. Pahor,et al.  Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study. , 2012, Journal of the American Medical Directors Association.

[5]  L. Perlmuter,et al.  A review of orthostatic blood pressure regulation and its association with mood and cognition , 2012, Clinical Autonomic Research.

[6]  K. Meguro,et al.  Sleep disturbance is associated with decreased daily activity and impaired nocturnal reduction of blood pressure in dementia patients. , 2011, Archives of gerontology and geriatrics.

[7]  P. Devi,et al.  Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital , 2011, European Journal of Clinical Pharmacology.

[8]  V. Mathura,et al.  Demonstration of safety in Alzheimer's patients for intervention with an anti‐hypertensive drug Nilvadipine: results from a 6‐week open label study , 2011, International journal of geriatric psychiatry.

[9]  R. Hubbard,et al.  Risk of falls associated with antihypertensive medication: self‐controlled case series , 2011, Pharmacoepidemiology and drug safety.

[10]  K. Ritchie,et al.  Latest advances on interventions that may prevent, delay or ameliorate dementia , 2011, Therapeutic advances in chronic disease.

[11]  A. Hofman,et al.  &bgr;-Blockers and the Risk of Incident Depression in the Elderly , 2011, Journal of clinical psychopharmacology.

[12]  M. Ziegler,et al.  Antihypertensive therapy for patients with obstructive sleep apnea , 2011, Current opinion in nephrology and hypertension.

[13]  O. Hanon,et al.  Relationship between orthostatic hypotension and cognitive impairment in the elderly , 2010, Journal of the Neurological Sciences.

[14]  I. Hajjar,et al.  The relationship between blood pressure and cognitive function , 2010, Nature Reviews Cardiology.

[15]  J. Hanlon,et al.  The Effect of Medication Use on Urinary Incontinence in Community‐Dwelling Elderly Women , 2010, Journal of the American Geriatrics Society.

[16]  Karim M Khan,et al.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons. , 2009, Archives of internal medicine.

[17]  Mark E Kunik,et al.  Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. , 2009, The American journal of geriatric pharmacotherapy.

[18]  E. Peskind,et al.  Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  A. Booth,et al.  A typology of reviews: an analysis of 14 review types and associated methodologies. , 2009, Health information and libraries journal.

[20]  C. Ballard,et al.  Incidence and Prediction of Falls in Dementia: A Prospective Study in Older People , 2009, PloS one.

[21]  H. Arntz,et al.  Antihypertensive Pharmakotherapie und Nierenfunktion bei geriatrischen Notfallpatienten , 2009, Deutsche medizinische Wochenschrift.

[22]  Y. Gustafson,et al.  Risk factors for falls among residents with dementia living in group dwellings , 2009, International Psychogeriatrics.

[23]  E. Londos,et al.  The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies , 2008, International journal of geriatric psychiatry.

[24]  Y. Gustafson,et al.  Erratum to: Characteristics associated with falls in patients with dementia in a psychogeriatric ward , 2007, Aging clinical and experimental research.

[25]  Y. Gustafson,et al.  Characteristics associated with falls in patients with dementia in a psychogeriatric ward , 2007 .

[26]  C. Wiysonge,et al.  How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis , 2006, Journal of hypertension.

[27]  Jennifer E. Graham,et al.  Hostility and pain are related to inflammation in older adults , 2006, Brain, Behavior, and Immunity.

[28]  Alessandro Padovani,et al.  Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy , 2005, International journal of geriatric psychiatry.

[29]  T. del Ser,et al.  Efficacy and Safety of Nimodipine in Subcortical Vascular Dementia: A Randomized Placebo-Controlled Trial , 2005, Stroke.

[30]  D. Tsuang,et al.  Propranolol for Disruptive Behaviors in Nursing Home Residents With Probable or Possible Alzheimer Disease: A Placebo-Controlled Study , 2005, Alzheimer disease and associated disorders.

[31]  N. Herrmann,et al.  Noradrenergic Activity is Associated with Response to Pindolol in Aggressive Alzheimer’s Disease Patients , 2004, Journal of psychopharmacology.

[32]  Sheryl Zimmerman,et al.  Dementia as a Risk Factor for Falls and Fall Injuries Among Nursing Home Residents , 2003, Journal of the American Geriatrics Society.

[33]  A. Grandi,et al.  Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade , 2002, Journal of hypertension.

[34]  Mats Thorslund,et al.  The Appropriateness of Drug Use in an Older Nondemented and Demented Population , 2001, Journal of the American Geriatrics Society.

[35]  C. Reid,et al.  A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs. , 2001, American journal of hypertension.

[36]  L. Pantoni,et al.  Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial , 2000, Journal of the Neurological Sciences.

[37]  A. Wallin,et al.  The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia , 2000, Journal of the Neurological Sciences.

[38]  R. Anand,et al.  Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty‐two classes of medications , 2000, International journal of geriatric psychiatry.

[39]  C. Cotman,et al.  Low‐Dose Propranolol Reduces Aggression and Agitation Resembling That Associated with Orbitofrontal Dysfunction in Elderly Demented Patients , 1995, Alzheimer disease and associated disorders.

[40]  L. Morey,et al.  Nimodipine in the treatment of old age dementias , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[41]  D. Mungas,et al.  Propranolol for the Control of Disruptive Behavior in Senile Dementia , 1988, Journal of geriatric psychiatry and neurology.

[42]  L. Kuller,et al.  Systolic Hypertension in the Elderly Program (SHEP) , 1986, Journal of the American Geriatrics Society.

[43]  Zacharias Fj.  Beta blockers in hypertension. , 1973, Bruxelles medical.

[44]  J. Gladman,et al.  The treatment of hypertension in care home residents: a systematic review of observational studies. , 2014, Journal of the American Medical Directors Association.

[45]  P. Kehoe,et al.  Associations of angiotensin targeting antihypertensive drugs with mortality and hospitalization in primary care patients with dementia. , 2013, Journal of Alzheimer's disease : JAD.

[46]  R. Payne,et al.  Polypharmacy and medicines optimisation: Making it safe and sound , 2013 .

[47]  A. Pariente,et al.  Factors Associated with Serious Adverse Reactions to Cholinesterase Inhibitors , 2010, CNS drugs.

[48]  K. Bassett,et al.  Pharmacotherapy for hypertension in the elderly (Review) , 2010 .

[49]  Maryse Lapeyre-Mestre,et al.  Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). , 2007, Drug safety.

[50]  Donald L Bliwise,et al.  Sleep disorders in Alzheimer's disease and other dementias. , 2004, Clinical cornerstone.

[51]  F. Shaw.  Falls in Older People With Dementia , 2003 .

[52]  S. Newman.  The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample. , 1999, Journal of affective disorders.

[53]  T. Asada,et al.  Predictors of fall-related injuries among community-dwelling elderly people with dementia. , 1996, Age and ageing.

[54]  T. Chalmers,et al.  Drug treatment of hypertension in the elderly: a meta-analysis. , 1994, Annals of internal medicine.

[55]  C. Dollery,et al.  Medical Research Council trial of treatment of hypertension in older adults: principal results. , 1992 .